Releasing Products, Closing Funding: November 1, 2018 Portfolio Update
New releases, major funding & prominent coverage for OIF portfolio companies
Whether it’s from a contribution to a major publication, a significant fundraising milestone or the launch of a promotional game, the Ohio Innovation Fund’s portfolio companies know how to grab attention. Keep reading to learn about some of the big steps taken by OIF portfolio companies over the latter half of October 2018.
Mezu Promotes Functionality with New In-App Game Show
To help spotlight its secure money transfer capabilities, privacy-conscious payment app Mezu recently unveiled Mezu Money Time, a live game show-style activity that gives out cash prizes three days a week. The game demonstrates the simplicity of the app, requiring only that participants quickly enter a four-digit code in order to win prizes, given out twice a day on Mondays, Wednesdays and Fridays.
“When we created Mezu, we focused on a fun and user-friendly user experience that highlighted our focus on privacy. Our Give and Get interface has an inherent and deliberate game-like feel and when we saw just how much users enjoyed it – we decided to follow their lead and turn it into an actual game inside the app.” –Yuval Brisker, Mezu CEO
Series B Round Closing Raises Up to $50 Million for Enable Injections
Self-injection delivery company Enable Injections just announced the first closing of a Series B funding round that will raise up to $50 million, including support from OIF. The company emphasized the contribution of global biopharmaceutical company Sanofi, which led the round of funding.
“This financing will enable the company to advance to a commercial scale and bring its first products to market. The investment and partnership with Sanofi provide that commercial validation.” –John Rice, Enable Injections Board Member
Immuta CPO Talks Regulations in Harvard Business Review
The highly respected Harvard Business Review on Oct. 23 published a piece by Andrew Burt, chief privacy officer of data management company Immuta, focused on the unintended consequences of new privacy regulations. The column warns of the risks inherent in overly broad privacy legislation and overreliance on user consent, and emphasizes the importance of carefully written rules, as well as incentives for smaller organizations to share data so they can compete with larger competitors.
Immuta was also recently profiled in eWeek, which you can read about here.